Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 9/20 | 0.76 |
| ▸ | GLO1 | Q04760 | 5/20 | 0.60 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.60 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.49 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.49 |
| ▸ | SNCA | P37840 | 3/20 | 0.47 |
| ▸ | DPP4 | P27487 | 2/20 | 0.47 |
| ▸ | EGFR | P00533 | 2/20 | 0.44 |
| ▸ | KDR | P35968 | 2/20 | 0.44 |
| ▸ | EP300 | Q09472 | 2/20 | 0.44 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 3/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.38 |
| ▸ | BCR | P11274 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29392598 | 0.98 | CD38 (0.73) | CD38GLO1OR51E2F2NR1H2 | |
| Hydrochloric Acid SCHEMBL1366891 | 0.98 | CD38 (0.73) | CD38GLO1OR51E2F2NR1H2 | |
| Hydrochloric Acid SCHEMBL29413086 | 0.98 | CD38 (0.73) | CD38GLO1OR51E2F2NR1H2 | |
| Hydrochloric Acid SCHEMBL11317960 | 0.97 | CD38 (0.71) | CD38GLO1OR51E2F2NR1H2 | |
| SCHEMBL11155009 | 0.88 | CD38 (0.69) | CD38GLO1OR51E2F2NR1H2 | |
| Luteolinidin SCHEMBL676808 | 0.86 | CD38 (1.00) | CD38GLO1OR51E2F2NR1H2 | |
| Luteolinidin SCHEMBL30159678 | 0.86 | CD38 (1.00) | CD38GLO1OR51E2F2NR1H2 | |
| SCHEMBL7045086 | 0.86 | CD38 (0.79) | CD38GLO1OR51E2F2NR1H2 | |
| Luteolinidin SCHEMBL676807 | 0.85 | CD38 (0.97) | CD38GLO1OR51E2F2NR1H2 | |
| SCHEMBL6131745 | 0.84 | CD38 (0.73) | CD38GLO1OR51E2F2NR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1172091-B1 | Use of 4',5,7-trihydroxyflavylium for coloring the skin | OREAL (FR) | 2006-06-07 | — | — | EP | claimed |
| EP-1172090-B1 | Skin dyeing compositions comprising dihydroxyacetone and a flavylium salt non substituted in position 3 | OREAL (FR) | 2005-03-09 | — | — | EP | claimed |
| EP-1172093-B1 | Compositions for coloring the skin containing flavylium salt compounds unsubstituted in position 3 and an organomodified silicone | OREAL (FR) | 2004-12-01 | — | — | EP | claimed |
| EP-1172092-B1 | Compositions for coloring the skin containing at least one UV filter and flavylium salt compounds unsubstituted in position 3 | OREAL (FR) | 2004-09-15 | — | — | EP | claimed |
| US-6558655-B2 | Substituted with at least one hydroxyl group or alkoxy radical. | Société l'Oréal S.A. (FR) | 2003-05-06 | — | — | US | claimed |
| US-6537528-B2 | Coloration close to that of a natural tan and which may be stable over time | L'OREAL S.A. (FR) | 2003-03-25 | — | — | US | claimed |
| WO-2003007910-A1 | COMPOSITIONS COMPRISING COMPOUNDS OF FLAVYLIUM SALT TYPE UNSUBSTITUTED IN POSITION 3 FOR SKIN COLOURING AND USES | L'OREAL (FR) | 2003-01-30 | — | — | WO | claimed |
| US-6511656-B2 | Compositions for coloring the skin comprising at least one flavylium salt which is unsubstituted in position 3 and at least one organomodified silicone | L'OREAL S.A. (FR) | 2003-01-28 | — | — | US | claimed |
| US-6471949-B2 | COSMETICS; FOR ARTIFICIALLY COLORING THE SKIN | L'OREAL S.A. (FR) | 2002-10-29 | — | — | US | claimed |
| US-20020064507-A1 | Compositions comprising at least one UV screening agent and at least one flavylium salt which is unsubstituted in position 3, for coloring the skin, and uses thereof | L'OREAL S.A. (FR) | 2002-05-30 | — | — | US | claimed |
| US-20020051755-A1 | Composition comprising at least one self-tanning agent chosen from monocarbonyl and polycarbonyl compounds and a flavylium salt compound which is unsubstituted in position 3, for coloring the skin, and uses thereof | L'OREAL S.A. (FR) | 2002-05-02 | — | — | US | claimed |
| US-20020048556-A1 | Compositions for coloring the skin comprising at least one flavylium salt which is unsubstituted in position 3 and at least one organomodified silicone | L'OREAL S.A (FR) | 2002-04-25 | — | — | US | claimed |
| US-20020048555-A1 | Artificial tanning compositions comprising flavylium salts | SOCIETE L'OREAL S.A. (FR) | 2002-04-25 | — | — | US | claimed |
| EP-1172090-A1 | Skin dyeing compositions containing at least a mono or polycarbonyl self-tanning compound and a flavylium salt non substituted in position 3 | L'OREAL (FR) | 2002-01-16 | — | — | EP | claimed |
| EP-1172091-A1 | Skin dyeing compositions containing flavylium salt compounds non substituted in position 3 | L'OREAL (FR) | 2002-01-16 | — | — | EP | claimed |
| EP-1172093-A1 | Skin dyeing compositions containing flavylium salt compounds non substituted in position 3 and an organomodified silicone | L'OREAL (FR) | 2002-01-16 | — | — | EP | claimed |
| US-6241785-B1 | HOIR DYES | L'OREAL (FR) | 2001-06-05 | — | — | US | claimed |
| EP-0949897-B1 | USE OF FLAVYLIUM TYPE COMPOUNDS NON-SUBSTITUTED IN POSITION 3 FOR DYEING KERATINOUS FIBRES AND COMPOSITIONS CONTAINING THEM | OREAL (FR) | 2001-05-23 | — | — | EP | claimed |
| EP-0949897-A1 | USE OF FLAVYLIUM TYPE COMPOUNDS NON-SUBSTITUTED IN POSITION 3 FOR DYEING KERATINOUS FIBRES AND COMPOSITIONS CONTAINING THEM | L'OREAL (FR) | 1999-10-20 | — | — | EP | claimed |
| WO-1998027940-A1 | USE OF FLAVYLIUM TYPE COMPOUNDS NON-SUBSTITUTED IN POSITION 3 FOR DYEING KERATINOUS FIBRES AND COMPOSITIONS CONTAINING THEM | L'OREAL (FR) | 1998-07-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020064507-A1 | Compositions comprising at least one UV screening agent and at least one flavylium salt which is unsubstituted in position 3, for coloring the skin, and uses thereof | TYR, CUTA, POLR1C | CD38 4238/4885GLO1 523/4885OR51E2 1061/4885 |
| US-20020048556-A1 | Compositions for coloring the skin comprising at least one flavylium salt which is unsubstituted in position 3 and at least one organomodified silicone | CUTA, LPO, TYR | CD38 4862/4885GLO1 98/4885OR51E2 356/4885 |
| US-20020048555-A1 | Artificial tanning compositions comprising flavylium salts | ADH7, TYR, HADHB | CD38 3003/4885GLO1 101/4885OR51E2 197/4885 |
| US-20020051755-A1 | Composition comprising at least one self-tanning agent chosen from monocarbonyl and polycarbonyl compounds and a flavylium salt compound which is unsubstituted in position 3, for coloring the skin, and uses thereof | TYR, CUTA, MITF | CD38 3110/4885GLO1 412/4885OR51E2 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.